Supriya Lifescience Limited
Stock Forecast, Prediction & Price Target

Supriya Lifescience Limited Financial Estimates

Supriya Lifescience Limited Revenue Estimates

Supriya Lifescience Limited EBITDA Estimates

Supriya Lifescience Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹3.85B
 
N/A
₹5.19B
 
34.77%
₹5.70B
 
9.81%
Avg: ₹8.57B
Low: ₹8.57B
High: ₹8.57B
avg. 50.26%
Avg: ₹11.14B
Low: ₹11.14B
High: ₹11.14B
avg. 29.98%
Net Income
 
% change YoY
₹1.23B
 
N/A
₹1.51B
 
22.83%
₹1.19B
 
-21.53%
Avg: ₹1.94B
Low: ₹1.94B
High: ₹1.94B
avg. 62.93%
Avg: ₹2.66B
Low: ₹2.66B
High: ₹2.66B
avg. 37.09%
EBITDA
 
% change YoY
₹1.78B
 
N/A
₹2.20B
 
23.79%
₹1.83B
 
-16.76%
Avg: ₹3.15B
Low: ₹3.15B
High: ₹3.15B
avg. 71.78%
Avg: ₹4.09B
Low: ₹4.09B
High: ₹4.09B
avg. 29.98%
EPS
 
% change YoY
$16.89
 
N/A
$18.86
 
11.66%
$14.8
 
-21.52%
Avg: $24.12
Low: $24.12
High: $24.12
avg. 62.93%
Avg: $33.06
Low: $33.06
High: $33.06
avg. 37.09%
Operating Expenses
 
% change YoY
₹735.79M
 
N/A
₹873.31M
 
18.69%
₹2.80B
 
220.90%
Avg: ₹885.74M
Low: ₹885.74M
High: ₹885.74M
avg. -68.39%
Avg: ₹1.15B
Low: ₹1.15B
High: ₹1.15B
avg. 29.98%

FAQ

What is Supriya Lifescience Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 50.01% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is 1.94B, average is 1.94B and high is 1.94B.

What is Supriya Lifescience Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 40.12% in 2026-2027.

We have gathered data from N/A analysts. Their low revenue estimate is ₹8.57B, average is ₹8.57B and high is ₹8.57B.

What is Supriya Lifescience Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 50.01% in 2026-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $24.12, average is $24.12 and high is ₹24.11.